Begin typing your search...

Rs 10L costs, ban on Patanjali’s ‘Coronil’ stayed

In a big relief to Patanjali Ayurved, the Madras High Court on Friday stayed the single judge’s order restraining it from using the word ‘Coronil’ for its immunity booster tablets and Rs 10 lakh costs for commercial exploitation of COVID-19 fear.

Rs 10L costs, ban on Patanjali’s ‘Coronil’ stayed
X

Chennai

A division bench comprising Justice R Subbiah and Justice C Saravanan suspended the injunction and allowed Patanjali to use ‘Coronil’ for two weeks following which it is scheduled to take up the matter for final hearing.

The order under challenge was passed by Justice CV Karthikeyan while allowing a trademark infringement suit by Chennai-based Arudra Engineering Private Limited. Arudra had registered the trademark for ‘CORONIL-92 B’ as an acid inhibitor product for industrial cleaning and use in June 1993.

Appearing for Patanjali, senior counsel Aryama Sundaram submitted that the trademark held by Arudra is a label mark and three are 191 companies using some derivative of ‘Corona’ term in their name. Moreover, Arudra with just about Rs 60 lakh per annum turnover cannot cry foul about their reputation being affected by a 100-cr company. Senior counsel PR Raman appearing for Arudra submitted that the as per the trade mark rules Arudra need not prove that there would be confusion between the products and that its reputation has been affected.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

migrator
Next Story